Annual Cash & Cash Equivalents
$98.43 M
-$57.72 M-36.96%
31 December 2023
Summary:
Cullinan Oncology annual cash & cash equivalents is currently $98.43 million, with the most recent change of -$57.72 million (-36.96%) on 31 December 2023. During the last 3 years, it has fallen by -$69.76 million (-41.48%). CGEM annual cash & cash equivalents is now -41.48% below its all-time high of $168.20 million, reached on 31 December 2020.CGEM Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$102.08 M
-$12.94 M-11.25%
30 September 2024
Summary:
Cullinan Oncology quarterly cash and cash equivalents is currently $102.08 million, with the most recent change of -$12.94 million (-11.25%) on 30 September 2024. Over the past year, it has increased by +$37.24 million (+57.42%). CGEM quarterly cash and cash equivalents is now -71.13% below its all-time high of $353.56 million, reached on 30 June 2022.CGEM Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CGEM Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.0% | +57.4% |
| 3 y3 years | -41.5% | +15.9% |
| 5 y5 years | +190.9% | - |
CGEM Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -41.5% | +64.7% | -71.1% | +70.8% |
| 5 y | 5 years | -41.5% | +190.9% | -71.1% | +70.8% |
| alltime | all time | -41.5% | -71.1% | +70.8% |
Cullinan Oncology Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $102.08 M(-11.2%) |
| June 2024 | - | $115.02 M(+55.0%) |
| Mar 2024 | - | $74.23 M(-24.6%) |
| Dec 2023 | $98.43 M(-37.0%) | $98.43 M(+51.8%) |
| Sept 2023 | - | $64.85 M(-54.3%) |
| June 2023 | - | $141.83 M(+16.1%) |
| Mar 2023 | - | $122.13 M(-21.8%) |
| Dec 2022 | $156.15 M(+161.2%) | $156.15 M(-35.6%) |
| Sept 2022 | - | $242.66 M(-31.4%) |
| June 2022 | - | $353.56 M(+364.5%) |
| Mar 2022 | - | $76.12 M(+27.3%) |
| Dec 2021 | $59.77 M | $59.77 M(-32.2%) |
| Sept 2021 | - | $88.11 M(-28.8%) |
| June 2021 | - | $123.67 M(-57.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $293.54 M(+74.5%) |
| Dec 2020 | $168.20 M(+165.9%) | $168.20 M(+1.3%) |
| Sept 2020 | - | $166.00 M(+162.4%) |
| Dec 2019 | $63.25 M(+87.0%) | $63.25 M |
| Dec 2018 | $33.83 M(>+9900.0%) | - |
| Dec 2016 | $100.00(0.0%) | - |
| Dec 2015 | $100.00(-94.4%) | - |
| Dec 2014 | $1800.00(-10.0%) | - |
| Dec 2013 | $2000.00(+566.7%) | - |
| Dec 2012 | $300.00(-66.7%) | - |
| Dec 2011 | $900.00(-35.7%) | - |
| Dec 2010 | $1400.00(+250.0%) | - |
| Dec 2009 | $400.00(>+9900.0%) | - |
| Dec 2008 | $0.00(-100.0%) | - |
| Dec 2007 | $6000.00 | - |
FAQ
- What is Cullinan Oncology annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Cullinan Oncology?
- What is Cullinan Oncology annual cash & cash equivalents year-on-year change?
- What is Cullinan Oncology quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Cullinan Oncology?
- What is Cullinan Oncology quarterly cash and cash equivalents year-on-year change?
What is Cullinan Oncology annual cash & cash equivalents?
The current annual cash & cash equivalents of CGEM is $98.43 M
What is the all time high annual cash & cash equivalents for Cullinan Oncology?
Cullinan Oncology all-time high annual cash & cash equivalents is $168.20 M
What is Cullinan Oncology annual cash & cash equivalents year-on-year change?
Over the past year, CGEM annual cash & cash equivalents has changed by -$57.72 M (-36.96%)
What is Cullinan Oncology quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CGEM is $102.08 M
What is the all time high quarterly cash and cash equivalents for Cullinan Oncology?
Cullinan Oncology all-time high quarterly cash and cash equivalents is $353.56 M
What is Cullinan Oncology quarterly cash and cash equivalents year-on-year change?
Over the past year, CGEM quarterly cash and cash equivalents has changed by +$37.24 M (+57.42%)